{
  "ticker": "VRTX",
  "year": 2022,
  "quarter": 4,
  "last_updated": "2025-04-15T14:01:53.509490",
  "count": 12,
  "transactions": [
    {
      "id": 22113,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-12-06",
      "transaction_shares": "12753",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "58031"
    },
    {
      "id": 42995,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-12-06",
      "transaction_shares": "12753",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "58031"
    },
    {
      "id": 22118,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-15",
      "transaction_shares": "34",
      "transaction_price": "308.61",
      "transaction_type": "S",
      "shares_after_transaction": "36077"
    },
    {
      "id": 43006,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-15",
      "transaction_shares": "34",
      "transaction_price": "308.61",
      "transaction_type": "S",
      "shares_after_transaction": "36077"
    },
    {
      "id": 22121,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-07",
      "transaction_shares": "1303",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37380"
    },
    {
      "id": 43010,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-11-07",
      "transaction_shares": "1303",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37380"
    },
    {
      "id": 22097,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-11-01",
      "transaction_shares": "768",
      "transaction_price": "312.84",
      "transaction_type": "F",
      "shares_after_transaction": "38424"
    },
    {
      "id": 42953,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-11-01",
      "transaction_shares": "768",
      "transaction_price": "312.84",
      "transaction_type": "F",
      "shares_after_transaction": "38424"
    },
    {
      "id": 22125,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-24",
      "transaction_shares": "621",
      "transaction_price": "310.00",
      "transaction_type": "S",
      "shares_after_transaction": "4040"
    },
    {
      "id": 43018,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-24",
      "transaction_shares": "621",
      "transaction_price": "310.00",
      "transaction_type": "S",
      "shares_after_transaction": "4040"
    },
    {
      "id": 22131,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-10-18",
      "transaction_shares": "1503",
      "transaction_price": "300.02",
      "transaction_type": "S",
      "shares_after_transaction": "39480"
    },
    {
      "id": 43035,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-10-18",
      "transaction_shares": "1503",
      "transaction_price": "300.02",
      "transaction_type": "S",
      "shares_after_transaction": "39480"
    }
  ]
}